Atossa Genetics logo
  • About Atossa
  • Programs
  • News/Media
  • Contact

All SEC Filings

  • Overview
  • News / Events
  • Company Information
  • Financial Information
  • Stock Information
  • SEC Filings
    • All SEC Filings
    • Section 16 Filings
  • Corporate Governance
Filter Filings:
Date Form Description Docs XBRL Pages
11/03/17 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
11/03/17 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5
10/31/17 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 9
10/30/17 8-K Current report filing
Related Documents
EX-1.1
EX-5.1
EX-99.1
EX-99.2
53
10/27/17 424B3 Prospectus filed pursuant to Rule 424(b)(3) 50
10/26/17 424B3 Prospectus filed pursuant to Rule 424(b)(3) 50
10/25/17 8-K Current report filing
Related Documents
EX-99.1
EX-99.2
58
10/05/17 EFFECT Notice of Effectiveness 1
10/03/17 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
10/03/17 UPLOAD SEC-generated letter 1
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...33
  • Next >>
  • Email Alerts
  • IR Contacts
  • RSS News Feed

Quick Links

  • About Atossa
  • Management
  • Investor Relations
  • Media
  • Careers
  • Legal
Atossa Genetics, Inc. • Corporate Office 107 Spring Street, Seattle, WA 98104 • (866) 893-4927   © 2018 Atossa Genetics, Inc.